159 related articles for article (PubMed ID: 38256511)
1. The Extent and Nature of Functional Limitations According to the Health Assessment Questionnaire Disability Index in Patients with Rheumatoid Arthritis and Severe Functional Disability.
Teuwen MMH; van Wissen MAT; Peter WF; van Schaardenburg D; van den Ende CHM; Gademan MGJ; van Weely SFE
J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256511
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with disability in patients with rheumatoid arthritis with persistent moderate disease activity: a retrospective cohort study.
Scott IC; Mount J; Barry J; Kirkham B
BMC Rheumatol; 2020; 4():63. PubMed ID: 33094270
[TBL] [Abstract][Full Text] [Related]
3. Functional disability associated with disease and quality-of-life parameters in Chinese patients with rheumatoid arthritis.
Ji J; Zhang L; Zhang Q; Yin R; Fu T; Li L; Gu Z
Health Qual Life Outcomes; 2017 May; 15(1):89. PubMed ID: 28464888
[TBL] [Abstract][Full Text] [Related]
4. Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.
Schiff MH; Yu EB; Weinblatt ME; Moreland LW; Genovese MC; White B; Singh A; Chon Y; Woolley JM
Drugs Aging; 2006; 23(2):167-78. PubMed ID: 16536638
[TBL] [Abstract][Full Text] [Related]
5. Validity of adopting a Health Assessment Questionnaire Disability Index less than 0.5 as a target in elderly rheumatoid arthritis patients.
Yoshii I; Chijiwa T; Sawada N
Clin Rheumatol; 2019 Dec; 38(12):3351-3360. PubMed ID: 31372851
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment.
Miwa Y; Takahashi R; Ikari Y; Maeoka A; Nishimi S; Oguro N; Hayashi T; Hatano M; Isojima S; Yanai R; Kasama T; Toyoshima Y; Inagaki K; Sanada K
Intern Med; 2017; 56(8):903-906. PubMed ID: 28420837
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid arthritis patients with low baseline Health Assessment Questionnaire scores have a risk of functional disability progression: a post hoc analysis of a nationwide longitudinal cohort in Japan.
Sumiyoshi R; Hidaka T; Koga T; Okada A; Fukuda T; Ishii T; Ueki Y; Kodera T; Nakashima M; Takahashi Y; Honda S; Horai Y; Watanabe R; Okuno H; Aramaki T; Izumiyama T; Takai O; Miyashita T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Eguchi K; Kawakami A;
Clin Exp Rheumatol; 2020; 38(6):1096-1101. PubMed ID: 32896260
[TBL] [Abstract][Full Text] [Related]
9. Associations between Health Assessment Questionnaire Disability Index and physical performance in rheumatoid arthritis and osteoarthritis.
Douglas-Withers J; McCulloch K; Waters D; Parker K; Hogg N; Mitsuhashi T; Treharne GJ; Abbott JH; Stebbings S
Int J Rheum Dis; 2019 Mar; 22(3):417-424. PubMed ID: 30560589
[TBL] [Abstract][Full Text] [Related]
10. Validation and reliability of the Timed Up and Go test for measuring objective functional impairment in patients with long-standing rheumatoid arthritis: a cross-sectional study.
Kojima T; Ishikawa H; Tanaka S; Haga N; Nishida K; Yukioka M; Hashimoto J; Miyahara H; Niki Y; Kimura T; Oda H; Asai S; Funahashi K; Kojima M; Ishiguro N
Int J Rheum Dis; 2018 Oct; 21(10):1793-1800. PubMed ID: 29210204
[TBL] [Abstract][Full Text] [Related]
11. Influence of pain score measured by a visual analog scale (PS-VAS) on the Health Assessment Questionnaire Disability Index and 28-joint Disease Activity Index with C-reactive protein in rheumatoid arthritis patients.
Yoshii I; Chijiwa T; Sawada N
Int J Rheum Dis; 2018 Nov; 21(11):1955-1961. PubMed ID: 30175554
[TBL] [Abstract][Full Text] [Related]
12. Impact of socio-demographic and clinical characteristics on functional disability and health-related quality of life in patients with rheumatoid arthritis: a cross-sectional study from Palestine.
Al-Jabi SW; Seleit DI; Badran A; Koni A; Zyoud SH
Health Qual Life Outcomes; 2021 Oct; 19(1):241. PubMed ID: 34645455
[TBL] [Abstract][Full Text] [Related]
13. Use of a "critical difference" statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritis.
Behrens F; Koehm M; Schwaneck EC; Schmalzing M; Gnann H; Greger G; Tony HP; Burkhardt H
BMC Rheumatol; 2019; 3():51. PubMed ID: 31867564
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.
Kumar BS; Suneetha P; Mohan A; Kumar DP; Sarma KVS
Indian J Med Res; 2017 Nov; 146(Supplement):S57-S62. PubMed ID: 29578196
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.
Twigg S; Hensor EMA; Emery P; Tennant A; Morgan AW;
J Rheumatol; 2017 Sep; 44(9):1331-1340. PubMed ID: 28668806
[TBL] [Abstract][Full Text] [Related]
16. Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.
Martin WJ; Shim M; Paulus HE; Chaudhari S; Feng J; Elashoff D; Hahn TJ; Ranganath VK;
J Clin Rheumatol; 2014 Sep; 20(6):301-5. PubMed ID: 25160011
[TBL] [Abstract][Full Text] [Related]
17. Disability and health-related quality of life in Chinese patients with rheumatoid arthritis: A cross-sectional study.
Zhou Y; Wang X; An Y; Zhang X; Han S; Li X; Wang L; Wang C; Wang Y; Yang R; Wang G; Lu X; Zhu P; Chen L; Liu J; Jin H; Liu X; Sun L; Wei P; Wang J; Chen H; Cui L; Shu R; Zhang Z; Li G; Li Z; Yang J; Li J; Jia B; Zhang F; Tao J; Lin J; Wei Q; Liu X; Ke D; Hu S; Ye C; Yang X; Li H; Huang C; Gao M; Li X; Song L; Wang Y; Wang X; Mu R; Su Y; Li Z
Int J Rheum Dis; 2018 Sep; 21(9):1709-1715. PubMed ID: 30345647
[TBL] [Abstract][Full Text] [Related]
18. Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis.
Nagasawa H; Kameda H; Sekiguchi N; Amano K; Takeuchi T
Mod Rheumatol; 2010 Aug; 20(4):337-42. PubMed ID: 20225006
[TBL] [Abstract][Full Text] [Related]
19. Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain.
Carreño A; Fernández I; Badia X; Varela C; Roset M
Value Health; 2011 Jan; 14(1):192-200. PubMed ID: 21211502
[TBL] [Abstract][Full Text] [Related]
20. Health care utilization and costs associated with functional status in patients with psoriatic arthritis.
Ogdie A; Hwang M; Veeranki P; Portelli A; Sison S; Shafrin J; Pedro S; Hass S; Hur P; Kim N; Yi E; Michaud K
J Manag Care Spec Pharm; 2022 Sep; 28(9):997-1007. PubMed ID: 36001101
[No Abstract] [Full Text] [Related]
[Next] [New Search]
